Skip to main content
. 2023 May 6;12(11):12299–12315. doi: 10.1002/cam4.5927

FIGURE 2.

FIGURE 2

(A) Cumulative incidence curves for new‐onset cancer and cancer‐related mortality stratified by drug exposure effects of SGLT2I and DPP4I before and after propensity score matching (1:1). (B) Cumulative incidence curves for different new‐onset cancer outcomes stratified by drug exposure effects of SGLT2I and DPP4I in the matched cohort.